ADVANCED/METASTATIC NSCLC
Clinical trials for ADVANCED/METASTATIC NSCLC explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC NSCLC trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cells engineered to attack lung cancer show promise in early trial
Disease control Recruiting nowThis study tests a new treatment for people with advanced non-small cell lung cancer that has not responded to standard therapies. The treatment uses specially engineered natural killer (NK) immune cells that target two cancer-related proteins on tumor cells. Participants receive…
Matched conditions: ADVANCED/METASTATIC NSCLC
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Morning or afternoon? new study tests best time for immunotherapy
Knowledge-focused Recruiting nowThis study looks at whether getting immunotherapy in the morning or afternoon changes how well it works for people with advanced lung cancer. About 350 patients will be randomly assigned to receive their treatment either before 11 AM or after 12 PM. The goal is to see if timing a…
Matched conditions: ADVANCED/METASTATIC NSCLC
Phase: PHASE2 • Sponsor: Liza Villaruz, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC